okredo logo
none title certification

UAB Biotechnologinės farmacijos centras "Biotechpharma" Finance - revenue, profit

eye icon
More information

EBITDA margin (%)

unlock data icon

Register and

explore Okredo data
More information

EBIT margin (%)

unlock data icon

Register and

explore Okredo data

EBITDA margin (%)

Login to see the data

EBIT margin (%)

Login to see the data

Financial statetment report

Price: €9.90
Premium users: 1.00 credit
Indicator
Turnover (€)
Sales per employee (€)info
Profit before tax (€)
Net Profit (€)
Profit per employee (€)info
Working capital requirementinfo
Debt-to-equity ratioinfo
Total profitability (%)info
Net profitability (%)info
Equity (€)
Amounts Payable And Liabilities (€)
Non-current Assets (€)
CurrentAssets (€)
EBITDA margin (%)info
EBITDA (€)info
EBIT margin (%)info
EBIT (€)info
2021
76,153,418
448,991
34,384,439
34,384,439
202,726
0.36
1.25
52.30
45.15
54,189,605
67,622,662
56,206,419
77,526,267
2022
123,919,188
709,651
60,120,244
60,120,244
344,292
0.27
0.60
56.37
48.52
97,117,629
58,745,860
85,544,582
82,060,375
2023
93,045,600
575,670
50,779,570
50,779,570
314,172
0.54
0.65
63.31
54.57
94,214,496
61,164,150
56,086,298
110,169,310
unlock data icon

Register and

explore Okredo data
2023
93,045,600
575,670
50,779,570
50,779,570
314,172
0.54
0.65
63.31
54.57
94,214,496
61,164,150
56,086,298
110,169,310
unlock data icon

Register and

explore Okredo data

2023

Turnover (€)

93,045,600 €Descended-25 % *

Sales per employee (€)

575,670 €Descended-19 % *

Profit before tax (€)

50,779,570 €Descended-16 % *

Net Profit (€)

50,779,570 €Descended-16 % *

Profit per employee (€)

314,172 €Descended-9 % *

Working capital requirement

0.54 Ascended100.00 % *

Debt-to-equity ratio

0.65 Ascended8.33 % *

Total profitability (%)

63.31 %Ascended12.31 % *

Net profitability (%)

54.57 %Ascended12.47 % *

Equity (€)

94,214,496 €Descended-3 % *

Amounts Payable And Liabilities (€)

61,164,150 €Ascended4 % *

Non-current Assets (€)

56,086,298 €Descended-34 % *

CurrentAssets (€)

110,169,310 €Ascended34 % *

*over the last year starting selected period